Sanofi Pasteur Vaxdesign Corporation
Records under this name other than the patents Sanofi Pasteur Vaxdesign Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Back to Sanofi Pasteur Vaxdesign Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,962,319 | Methods for Testing an Immune Response Using Cultures of T Cells, B Cells, Dendritic Cells and Follicular Dendritic Cells No holder on record Term ended Ended no later than Aug 10, 2026 · Low confidence | Term ended | Ended no later than Aug 10, 2026 | Low confidence |
| US 7,785,883 | Automatable Artificial Immune System (AIS) Term ended Term ended Jul 27, 2026 · High confidence | Term ended | Term ended Jul 27, 2026 | High confidence |
| US 7,855,074 | Artificial Immune System: Methods for Making and Use Term ended Term ended Jul 27, 2026 · High confidence | Term ended | Term ended Jul 27, 2026 | High confidence |
| US 7,785,806 | Method for Determining the Immunogenicity of an Antigen Term ended Term ended Mar 27, 2026 · High confidence | Term ended | Term ended Mar 27, 2026 | High confidence |
| US 8,298,823 | Methods for Antibody Production Term ended Ended no later than Jan 29, 2026 · Medium confidence | Term ended | Ended no later than Jan 29, 2026 | Medium confidence |
| US 9,625,444 | Artificial Immune System: Methods of Use Term ended Term ended Nov 23, 2025 · Medium confidence | Term ended | Term ended Nov 23, 2025 | Medium confidence |
| US 8,288,159 | Artificial Immune System: Methods for Making and Use Term ended Ended no later than Sep 22, 2025 · Medium confidence | Term ended | Ended no later than Sep 22, 2025 | Medium confidence |
| US 7,709,256 | Disease Model Incorporation into an Artificial Immune System (AIS) Term ended Term ended Jun 6, 2025 · High confidence | Term ended | Term ended Jun 6, 2025 | High confidence |
| US 7,771,999 | Disease Model Incorporation into an Artificial Immune System (AIS) Term ended Term ended Jun 6, 2025 · High confidence | Term ended | Term ended Jun 6, 2025 | High confidence |
| US 8,071,373 | Co-Culture Lymphoid Tissue Equivalent (LTE) for an Artificial Immune System (AIS) Term ended Term ended May 6, 2025 · Medium confidence | Term ended | Term ended May 6, 2025 | Medium confidence |